NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-302-1998-0-US-08 Induction of Antigen-Specific Unresponsiveness by Glioblastoma Culture Supernatant(GCS) US National Stage 09/936,537 6884413 Abandoned PDF
NICHD E-286-1998-0-US-03 Prevention of Fetal Alcohol Syndrome and Neuronal Cell Death With ADNF Polypeptides US National Stage 09/936,888 7863247 Abandoned PDF
NCI E-074-1999-1-US-02 Cyanovirins Conjugates and Matrix-Anchored Cyanovirins and Methods of Use US DIV 09/951,189 7105169 Expired PDF
NHLBI E-261-2000-0-PCT-02 Optimization of Cardiac Contraction Through Differential Phosphorylation of Myosin PCT PCT PCT/US01/28639 Expired
NICHD E-209-2001-0-US-01 Neurotrophic Components of The ADNF 1 Complex US 60/322,760 Abandoned
NINDS E-177-1999-2-PCT-01 A System and Method for Identifying T Cell Epitopes and the Like PCT PCT COMB PCT/US01/42166 Expired
NCI E-041-2002-0-US-01 Liposomal Nystatin Treatment of Fungal Infection US ORD 09/950,980 Abandoned
NCI E-200-2001-0-US-01 Agents that Bind To And Inhibit Human Cytochrome P450 2C19 US ORD 09/950,431 6908738 Expired PDF
NCI E-149-2001-0-US-01 Novel Nitric Oxide Releasing Imidate And Thioimidate Diazeniumdiolates Compositions, Uses Thereof And Method of Making Same US ORD 09/950,162 6673338 Abandoned PDF
NCI E-037-2001-0-US-01 Method And Composition for Enhancing an Immune Response US 60/318,185 Abandoned
NCI E-029-1998-0-US-09 RECOMBINANT ANTI-TUMOR RNASE US DIV 09/948,391 7189393 Abandoned PDF
NIDDK E-071-1994-1-US-04 ANALOGUE POLYPEPTIDES WITH BROAD CARCINOMA SPECIFICITY AND ANTI-SENSE POLYPEPTIDES, HYBRIDOMA, KIT AND DIAGNOSTIC, VACCINATION AND... US DIV 09/947,839 6936706 Expired PDF
NIEHS E-170-2000-0-PCT-02 A Non-Steroidal Anti-Inflammatory Drug Activated Gene With Anti-Tumorigenic Properties PCT PCT PCT/US2001/027544 Expired
NHLBI E-192-2000-0-US-02 Modulating Response to Genotoxic Stress US ORD 09/947,258 Abandoned
NIDCR E-295-2001-0-US-01 Imaging The Activity of Extracellular Proteases In Cells Using Mutant Anthax Toxin Protective Antigens That Are Cleaved By Specific... US 60/317,550 Abandoned
NCI E-244-1997-3-JP-05 Novel Vacuolar (H+)-ATPase-Inhibitory Compositions and Uses Thereof JP National Stage 2000-602057 Abandoned
NIDDK E-245-1992-0-US-06 ARALKYL DIAZABICYCLOALKANE DERIVATIVES FOR CNS DISORDERS US CON 09/946,284 6656930 Abandoned PDF
NIEHS E-121-1996-0-AU-03 Transformation-Associated Recombination (TAR) System in Yeast for Specific Cloning of DNAs as Yeast Artificial Chromosomes (YACs) AU National Stage 65620/01 Abandoned
NCI E-302-2000-2-AU-05 Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway As Selective Therapeutic Strategy Against Melanomas AU National Stage 2001288562 Abandoned
NIDDK E-058-2000-2-US-01 Mass Spectrometry of Colonization Factors US CIP 09/942,974 6797485 Abandoned PDF
NCI E-071-1992-1-US-05 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS OF mRNA US CON 09/943,722 6794498 Expired PDF
NCI E-161-2000-0-PCT-02 XAGE-1, A GENE EXPRESSED IN MULTIPLE CANCERS, AND USES THEREOF PCT PCT PCT/US01/27258 Expired
NCI E-302-2000-2-PCT-01 Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway As Selective Therapeutic Strategy Against Melanomas PCT PCT COMB PCT/US01/27063 Expired
NCI E-302-2000-2-US-02 Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway As Selective Therapeutic Strategy Against Melanomas US ORD 09/942,940 Abandoned
NCI E-302-2000-2-EP-06 Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway As Selective Therapeutic Strategy Against Melanomas EP National Stage 01968307.7 Abandoned
NCI E-188-1996-0-AU-10 MELANOMA CELL LINES EXPRESSING SHARED IMMUNODOMINANT MELANOMA ANTIGENS AND METHODS OF USING SAME AU DIV 65575/01 Abandoned
NIMH E-247-2001-0-US-01 Effect of BDNF Genotype on verbal Memory And Risk For Schizophrenia US 60/316,736 Abandoned
NCI E-335-2001-0-US-01 Methods of Generating Human CD4+ TH1 Cells US 60/316,854 Abandoned
NCI E-064-2001-0-US-01 Parallel Measurements of Multiple RNA, Proteins And Antibody Binding Using CryoArray US 60/316,544 Abandoned
NCI E-302-2000-2-CA-03 Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway: A Selective Therapeutic Strategy Against Melanomas CA National Stage 2419567 Abandoned
NCI E-236-2001-0-US-01 New Adenovirus Type 7 Vectors US 60/316,361 Abandoned
NCI E-124-1996-0-US-04 FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVATING GENE I AND RELATED COMPOSITIONS AND METHODS US DIV 09/942,858 6608181 Expired PDF
NCI E-117-1996-0-AU-06 VECTORS FOR DELIVERING VIRAL AND ONCOGENIC INHIBITORS AU National Stage 65499/01 Abandoned
NIDCR E-044-1998-0-US-03 Methods of Treating Chronic Pain US National Stage 09/787,660 6596269 Expired PDF
NCI E-198-2001-0-US-01 Use of a Histone Deacetylase Inhibitor to Increase The Entry of an Adenoviral Agent Into a Cell US 60/315,008 Abandoned
NICHD E-259-2000-0-US-02 Protein Kinase A and Carney Complex US ORD 09/935,916 6759525 Expired PDF
NIDCR E-219-1998-0-US-03 Artificial Salivary Gland US CON 09/938,706 6743626 Abandoned PDF
NIDDK E-242-2001-0-US-01 Stable Monomer of The HIV-1 Protease And Methods of Their Use US 60/314,388 Abandoned
NIDCR E-320-2001-0-US-01 A Composition And Method For Inhibting Angiogenesis And Cell Proliferation US 60/314,561 Abandoned
NCI E-150-2001-0-US-01 Use of a Promotor of T-Cell Expansion And an Inducer of CD40 Stimulation in The Treatment or Prevention of a Pathologic State US 60/314,342 Abandoned
NCI E-262-2000-0-US-03 SH2 Domain Binding Inhibitors US National Stage 10/362,231 6977241 Abandoned PDF
NCI E-262-2000-0-PCT-02 SH2 Domain Binding Inhibitors PCT PCT PCT/US01/26078 Expired
NCI E-262-2000-0-EP-06 SH2 Domain Binding Inhibitors EP National Stage 01964256.0 Abandoned
CC E-239-2001-1-US-01 Vessel Surface Reconstruction With A Tubular Deformable Model US ORD 09/934,968 Abandoned
NCI E-262-2000-0-AU-04 SH2 Domain Binding Inhibitors AU National Stage 2001285133 Abandoned
NCI E-086-2001-0-US-01 Peptides of a Melanoma Antigen and their Use in Diagnostic, Prophylactic and Therapeutic Methods US 60/314,183 Abandoned
NCI E-262-2000-0-CA-05 SH2 Domain Binding Inhibitors CA National Stage 2419870 Abandoned
NIAID E-246-2001-0-US-04 Immunization For Ebola Virus Infection US National Stage 09/913,909 6852324 Expired PDF
NCI E-123-2000-0-PCT-02 Method of Treating Cutaneous T-Cell Lymphoma By Administering A Histone Deacetylase Inhibitor PCT PCT PCT/US01/25827 Abandoned
NCI E-206-1995-3-US-10 FUNCTIONAL ROLE OF ADRENOMEDULLIN (AM) AND THE GENE-RELATED PRODUCT (PAMP) IN HUMAN PATHOLOGY AND PHYSIOLOGY` US DIV 09/931,700 7101548 Expired PDF